Products Produced at Kankakee Site

Finished Products:
Zemaira® / Respreeza®
Alpha1 proteinase inhibitor (A1Pl) indicated for chronic augmentation and maintenance in adults with A1Pl deficiency and clinical evidence of emphysema.

Used in the treatment of shock due to burns, trauma, operations, and infections, in the treatment of severe injuries, and in other similar conditions where the restoration of blood volume is urgent.

Used for the prevention and control of bleeding in Factor IX deficiency, also known as Hemophilia B or Christmas disease.

Afluria® (Fill and finish only)
Inactivated influenza vaccine for active immunization against influenza disease caused by influenza subtypes A and type B present in the vaccine for persons 5 years of age and older.

We also produce intermediates for products produced at other CSL Behring facilities.